Current Position: Professor
Education:
Purdue University, B.S., 1971, Biological Education
Purdue University, M.S., 1973, Cell Physiology
Purdue University, Ph.D., 1975, Biochemistry
Professional Experience:
Undergraduate Assistant, Dept. of Biology, Purdue University, Lafayette, Indiana, 1970
Graduate Assistant, Dept. of Biology, Purdue University, Lafayette, Indiana, 1971-1975
Research Fellow, Dept. of Immunopathology, The Scripps Research Institute, La Jolla, California, 1975-1977
Research Associate, Dept. of Cellular and Developmental Immunology, TSRI, 1977
Assistant Professor I, Dept. of Cellular and Developmental Immunology, TSRI, 1977-1978
Assistant Professor II, Dept. of Cellular and Developmental Immunology, TSRI, 1978-1982
Associate Professor, Tenured, Dept. of Molecular Biology,TSRI, 1982-1993
Professor, Dept. of Molecular Biology, TSRI, 1993-Present
Professional Organizations:
American Association for the Advancement of Science (AAAS)
American Society for Microbiology (ASM)
Honors and Activities - (10 years)
-Cancer Research Institute fellow, 1977-1980.
-Session Chairman, Virion Structure and Assembly, Cold Spring Harbor RNA Tumor Viruses Meeting l981.
-Invited Speaker, NCI Workshop on Hybridomas, National Cancer Institute, National Institutes of Health l981.
-Invited Speaker, Recombinant retroviruses and Murine Leukemia, The Jackson Laboratory, Bar Harbor, Maine l981.
-Advisory Committee, Cancer Special Review Committee, National Cancer Institute, National Insitutes of Health l981.
-Invited Lecturer, Feline Leukemia Virus Workshop, National Cancer Institute, National Institutes of Health l984.
-Invited Speaker, Retrovirus Vaccine Workshop, National Insitutes of Health l984.
-Advisory Committee, Studies of Bovine Leukemia Virus, National Cancer Institue, National Institutes of Health l985.
-Advisory Committee, Duke University, National Cancer Institute l985.
-Advisory Committee, Progress in AIDS Research, National Institutes of Health l985.
-Invited Lecturer, Vaccines against HIV and AIDS, National Academy of Sciences, Washington, D.C. l987.
-Appointed to Editorial Board, Analytical Biochemistry l987.
-Invited Speaker, UCLA Symposium, Peptides: Approaches to Biological Problems, Park City, Utah l988.
-Invited Speaker, Directions for Vaccine Development, National Cancer Institute, National Institutes of Health l988.
-Invited Lecturer, Conference on Retroviruses and Disease, Crete, Greece l988.
-Invited Speaker, Current Perspectives in AIDS, Annenberg Center, Rancho Mirage, CA l989.
-Invited Speaker, Animal Models for AIDS, FASEB Symposium on AIDS, New Orleans, LA l989.
-Permanent Member, Study Section AIDS and Related Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health l989.
-Invited Lecturer, Molecular Characterization of Feline Immunodeficiency Virus, American Association for the Advancement of Science Annual meeting, New Orleans, LA l990.
-Appointed to Editorial Board, Journal of Cellular Biochemistry l990.
-Appointed to Editorial Board, Journal of Virology l990.
-Appointed to Editorial Board, Virology l991.
-Invited Lecturer, Conference on Feline Immunodefiency Virus, Loch Lomand, Scotland l991.
-Session Chairman, First International Conference on Feline Immunodeficiency Virus, University of California, Davis, CA l991.
-Invited Participant, Human T-cell Lymphotropic Virus Induced Diseases: Protective Immune Responses and Potential for Vaccine Development, Division of Cancer Etiology of the National cancer Institute, National Institutes of Health l992.
-Session Chairman, RNA Tumor Virus Meeting, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1993.
-Invited Lecturer, Strategies for Development of Intervention Therapies Against FIV, Vlieland FIV Workshop, Vlieland, The Netherlands 1993.
-Session Chairman, Animal Models, Pathogenesis of HIV Infection of the Brain: Impact on Function and Behavior Conference, Chantilly, VA 1994.
-Session Chairman, Retroviruses Meeting, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1994.
-Faculty Professor, The Scripps Research Institute Graduate Program, La Jolla, CA, 1994-present.
-Invited Consultant, FAVEUR, Fourth International Retrovirus Research Symposium (FIFRRS), Glasgow, Scotland 1998.
-Co-Chairman, Receptors and Early Pathogenesis, Fourth International Retrovirus Research Symposium (FIFRRS), Glasgow, Scotland 1998.
-Permanent Member, CSR, AIDS & Related Research Review Group, Bethesda, MD 1999-2003.
BIBLIOGRAPHY (with links to PubMed)
1) Elder, J.H., C.A. Lembi, and D.J. Morre. (1970) Toxicity of 2,4-D and picloram to fresh and salt water algae. Proc. North Centr. Weed Contr. Conf. 25:96-98.
2) Sargeant, M., D. Blazek, J.H. Elder, C.A. Lembi, and D.J. Morre. (1970) The toxicity of 2,4-D and picloram herbicides to fish. Proc. Ind. Acad. Sci. 80;114-123.
3) Elder, J.H., C.A. Lembi, L. Anderson, and D.J. Morre. (1971) Scale calcification in a chrysophycean alga: a test system for the effects of DDT on biological calcification. Proc. Ind. Acad. Sci. 81:106-113.
4) Yunghans, W.N., J.H. Elder, B. Wintersteen, and D.J. Morre. (1973) Inhibition by DDT of calcium accumulation in isolated cell fractions from rat muscle. Proc. Ind. Acad. Sci. 83:113-119.
5) Elder, J.H. and D.J. Morre. (1974) Distribution and biosynthesis of hydrophobic proteins among rat liver endomembranes. Proc. Amer. Soc. Cell Biol. 63:92a.
6) Morre, D.J., J.H. Elder, C.L. Jelsema, T.W. Keenan, and W.D. Merrit. (1974) Sites of membrane biogenesis within the endomembrane system of rat liver. Proc. Elec. Micros Soc. Amer. Symposium on membrane biogenesis. R.J. Barnett (ed)., Wiley Interscience Press.
7) Elder, J.H., D.J. Morre, and T.W. Keenan. (1976) Distribution of glycoproteins among subcellular fractions from rat liver. Cytobiologic 13:279-284.
8) Elder, J.H. and D.J. Morre. (1976) Synthesis in vitro of intrinsic membrane proteins by free, membrane-bound, and Golgi apparatus-associated polysomes from rat liver. J. Biol. Chem. 251:5054-5068.
9) Del Villano, B.C., R.A. Lerner, S.J. Kennel, and J.H. Elder. (1976) Expression of an oncornavirus gene product in the mouse genital tract. In: Proceedings of the Third Annual NICHD Workshop of the Testis, pub. University of Pittsburg School of Medicine, eds., Raven Press, New York.
10) Elder, J.H., F.C. Jensen, M.L. Bryant, and R.A. Lerner. (1977) Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family. Nature 267:23-28.
11) Elder, J.H., R.A. Pickett, J. Hampton, and R.A. Lerner. (1977) Radioiodination of proteins in single polyacrylamide gel slices: tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein. J. Biol. Chem. 252:6510-6515.
12) Elder, J.H., J.W. Gautsch, F.C. Jensen, M. Vogt, and R.A. Lerner. (1977) Structural analysis of surface glycoproteins (gp70) of recombinant-C-type viruses. Evidence for envelope recombination. In: Advances in Comparative Leukemia Research. Bentvelzen et al. (eds), North Holland Biomedical Press, pp. 156.
13) Elder, J.H., J. Gautsch, F.C. Jensen, R.A. Lerner, J.W. Hartley, and W.P. Rowe. (1977) Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc. Natl. Acad. Sci. USA 74:4676-4680.
14) Bordier, C., W.F. Loomis, J.H. Elder, and R.A. Lerner. (1978) The major developmentally regulated protein complex in membranes of Dictyostelium. J. Biol. Chem. 253:5133-5139.
15) Bryant, M.L., B.K. Pal, M.B. Gardner, J.H. Elder, F.C. Jensen, and R.A. Lerner. (1978) Structural analysis of the major envelope glycoprotein (gp70) of the amphotropic and ecotropic type C viruses of wild mice. Virology 84:348-358.
16) Elder, J.H., J.W. Gautsch, F.C. Jensen, and R.A. Lerner. (1978) Generation of diversity among murine C-type viruses via envelope gene recombination. In: Differentiation of Normal and Neoplastic Hematopoietic cells, Cold Spring Harbor Laboratory, pp. 553-560.
17) Elder, J.H., J.W. Gautsch, F.C. Jensen, and R.A. Lerner. (1978) Multigene family of endogenous retroviruses: recombinant origin of diversity. Invited editorial, J. Nat. Cancer Inst. 61:625-638.
18) Gautsch, J.W., J.H. Elder, J. Schindler, F.C. Jensen, and R.A. Lerner. (1978) Structural markers on MuLV p30: Functional correlation with Fv-1 tropism. Proc. Nat. Acad. Sci. USA 75:4170-4174.
19) Buchmeier, M.J., J.H. Elder, and M.B.A. Oldstone. (1978) Protein structure of lymphocytic choriomeningitis virus: identification of the virus structural and cell associated polypeptides. Virology 89:113-145.
20) Takemoto, L.J., C.F. Fox, F.C. Jensen, J.H. Elder, and R.A. Lerner. (1978) Nearest-neighbor interactions of RNA tumor virusa glycoprotein, gp70, on the surface of murine cells. Proc. Natl. Acad. Sci. USA 75:3644-3648.
21) Ihle, J.N., P. Fischinger, D. Bolognesi, J.H. Elder, and J.W. Gautsch. (1978) B-MUX: A unique murine C-type virus containing the "env" gene of xenotropic viruses and the "gag" gene of the ecotropic virus. Virology 90:255-264.
22) Fischinger, P.J., A.E. Frankel, J.H. Elder, R.A. Lerner, J.N. Ihle, and D.P. Bolognesi. (1978) Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology 90:241-254.
23) Oskarsson, M., J.H. Elder, J.W. Gautsch, R.A. Lerner, and G.F. Vande Woude. (1978). Chemical determination of the m1Moloney sarcoma virus pP60gag gene order: Evidence for unique peptides in the C-terminus of the polyprotein. Proc. Natl. Acad. Sci. USA 75:4694-4698.
24) Fischinger, P.J., A.E. Frankel, J.H. Elder, R.A. Lerner, J.N. Ihle, and D.P. Bolognesi. (1978) Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology 90:241-254.
25) Elder, J.H., D.J. Morre, W.N. Yunghans. (1979) Calcium Uptake by Sarcoplasmic Reticulum of Rat Muscle: Inhibition by DDT. Eur J Cell Biol 19:231-238.
26) Gautsch, J.W., J.H. Elder, F.C. Jensen, and R.A. Lerner. (1979) In vitro construction of B-tropic virus by recombination: B-tropism is a cryptic phenotype of xenotropic murine retroviruses. Proc. Natl. Acad. Sci. 77:2989-2993.
27) Green, M., K. Brackmann, W.S, M. Wold, M. Cartas, H. Thornton, and J.H. Elder. (1979) Conserved primary sequences of the DNA terminal proteins of five different human denovirus groups. Proc. Natl. Acad. Sci. 76:4380-4384.
28) Zhdanov, V.M., J.H. Elder, R. Lerner, V.T. Ivanova, S.S. Iamnikova. (1979) Comparative characteristics of the peptide maps of the major proteins of influenza viruses type A. Vopr. Virusol. 2:109-115.
29) Green, M., H. Hiai, J.H. Elder, R.S. Schwartz, R.H. Khiroya, C.Y. Thomas, P.N. Tsichlis, and J.M. Coffin. (1980) Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J. Exp. Med. 152:249-264.
30) Elder, J.H., J.W. Gautsch, F.C. Jensen, R.A. Lerner, T.M. Chused, H.C. Morse, J.W. Hartley, and W.P. Rowe. (1980) Differential expression of two distinct xenotropic viruses in NZB mice. Clinical Immunology and Immunopathology 15:493-501.
31) Bubbers, J.E., J.H. Elder, and F.J. Dixon. (1980) Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro. J. of Immunology 124:388-394.
32) Fischinger, P.J., J.N. Ihle, J-P Levy, D.P. Bolognesi, J.H. Elder, and W. Schafer. (1980) Recombinant murine leukemia viruses and protective factors in leukemogenesis. Cold Spring Harbor Symposium, September 1980, 7:989-1003.
33) Niman, H. and J.H. Elder. (1980) Molecular dissection of Rauscher-derived envelope gene recombinants. Proc. Natl. Acad. Sci. USA 77:4524-4528.
34) Mohagheghpour, N., B. Parhami, K. Dowlatshahi, D. KakjeHnouri, J.H. Elder, and F.V. Chisari. (1979) Immunoregulatory properties of human esophageal tumor extract. J. Immun. 122:1350-1358.
35) Gautsch, J.W., J.H. Elder, F.C. Jensen, and R.A. Lerner. (1980) Structural diversity among retroviral gene products: A molecular approach to the study of biological function through structural variability. Adv. Cancer Res. 34:171-209.
36) Theofilopoulos, A.N., D.L. Shawler, R.S. Balderas, J.H. Elder, D.H. Katz, and F.J. Dixon. (1980) Specificities of NZB anti-H-2d CML reactions: Role of Qa-1 an retroviral gp70 antigens. J. Immun. 126:1115-1153.
37) Gisselbrecht, S., P.J. Fischinger, J.H. Elder, and J-P Levy. (1980) Isolation of two novel envelope recombinant, leukemogenic viruses from Moloney leukemia virus stocks. Inter. J. Cancer 27:531-536.
38) Fischinger, P.J., H.J. Thiel, J.M. Ihle, J.C. Lee, and J.H. Elder. (1980) Detection of a recombinant murine leukemia virus-like glycoprotein on virus-negative thymoma cells. Proc. Natl. Acad. Sci. USA 78:1920-1924.
39) Niman, H.L. and J.H. Elder. (1981) Structural analysis of Raucher virus gp70 using monoclonal antibodies: Sites of antigenicity and pl5e linkage. Virology 123:187-205.
40) Hara, I., S. Izui, P.J. McConahey, J.H. Elder, F.C. Jensen, and F.J. Dixon. (1981) Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 78:4397-4401.
41) Niman, H.L. and J.H. Elder. (1981) Monoclonal antibodies as probes of protein structure: Molecular diversity among the envelope glycoproteins (gp70s) of the murine retroviruses. In: Monoclonal Antibodies and T Cell Products. D.H. Katz (ed), CRC Press, Boca Raton, Florida, pp. 23-51.
42) Izui, S., J.H. Elder, P.J. McConahey, and F.J. Dixon. (1981) Identification of retroviral gp70 and anti-gp70 antibodies involved in circulating immune complexes in NZBxNZW mice. J. Exp. Med. 153:1151-1160.
43) Izui, S., I. Hara, V.E. Kelley, J.H. Elder, P.J. McConahey, and F.J. Dixon. (1982) Retroviral gene expression and murine systemic lupus erythematosus. VIII Int'l Immunopathology Symposium, October 26-31. F.J. Dixon, P. Miescher (eds.), Academic Press, New York, NY, pp. 263-283.
44) Witte, O.N., A. Ponticelli, A. Gifford, D. Baltimore, N. Rosenberg, and J.H. Elder. (1981) Phosphorylation of the abelson murine leukemia virus transforming protein. J. Virol. 39:870-878.
45) Elder, J.H. and S. Alexander. (1982) Endo-N-acetylglucosa-minidase F: Endoglycosidase from Flavobacterium meningosepticum which cleaves both "high mannose" and "complex" type glycoproteins. Proc. Natl. Acad. Sci. 79:4540-4544.
46) Fox, R.I., D. Harlow, I. Royston, and J.H. Elder. (1982) Structural characterization of the human T-cell surface antigen (p67) isolated from normal and neoplastic lymphocytes. J. Immunol. 129:401-405.
47) Elder, J.H. and J.I. Mullins. (1983) Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine MCF virus. J. Virol. 46:871-880.
48) Johnson, D.A. and J.H. Elder. (1983) Antibody directed to determinants of a Moloney virus derived MCF gp70 recognizes antigens on normal immature thymus cells, brain, testes, and murine leukemia cells. J. Exp. Med. 159:1751-1756.
49) Sparks, R.B. and J.H. Elder. (1983) A simple and rapid procedure for the purification of plasmid DNA using reverse-phase C18 silica beads. Anal. Biochem. 135:345-348.
50) Oldstone, M.B.A., F. Jensen, J.H. Elder, F.J. Dixon, and P.W. Lampert. (1983) Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus III. Role of input virus and MCF recombinants in disease. Virology 128:154-165.
51) Borst, J., S. Alexander, J.H. Elder, and C. Terhorst. (1983) The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J. Biol. Chem. 258:5135-5141.
52) Federici, A.B., J.H. Elder, L. DeMarco, Z.M. Rigger, and T.S. Zimmerman. (1984) The carbohydrate moiety of Von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. J. Clin. Investigation 74: 2049-2055.
53) Johnson, D.A., J.W. Gautsch, R. Sportsman, and J.H. Elder. (1984) Improved technique utilizing non-fat dry milk for analysis of protein and nucleic acids transferred to nitrocellulose. Gene Analysis Techniques 1:3-8.
54) Elder, J.H. and M. Munson. (1984) Modification of Western blotting technique for detection and quantitation of infectious virus. Biotechniques 2:170-172.
55) Alexander, S. and J.H. Elder. (1984) Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science 226:1328-1330.
56) Elder, J.H. (1984) The role of recombinant retroviruses in murine leukemia. In: Concepts in Viral Pathogenesis. A.L. Notkins and M.B.A. Oldstone (eds.). Springer-Verlag, New York, pp. 86-93.
57) Plummer, T.H., J.H. Elder, S. Alexander, A.W. Phelan, and A.L. Tarentino. (1984) Demonstration of peptide: N-glycosidase F activity in endo-B-N-acetylglucosaminidase F preparations. J. Biol. Chem. 259:10700-10704.
58) Sportsman, J.R. and J.H. Elder. (1984) A microanalytical protein assay using laser densitometry. Anal. Biochem. 139:298-300.
59) Izui, S. I. Hara, L.M. Hang, J.H. Elder, P.J. McConahey, F.J. Dixon. (1984) Association of Elevated Serum Glycoprotein gp70 with Increased gp70 Immune Complex Formation and Accelerated Lupus Nephritis in Autoimmune Male BXSB Mice. Clin Exp Immunlo 56:272-280.
60) Sportsman, J.R., M.M. Park, D.A. Cheresh, M. Fukuda, J.H. Elder, and R.I. Fox. (1985) Characterization of a membrane surface glycoprotein associated with T-cell activation. J. Immun. 135:158-164.
61) Elder, J.H., J.S. McGee and S. Alexander. (1986) Carbohydrate side chains of Rauscher leukemia virus envelope glycoproteins are not required to elicit a neutralizing antibody response. J. Virol. 57:340-342.
62) Fujimura, Y., K. Titani, L.Z. Holland, S.R. Russell, J.R. Roberts,J.H. Elder, Z.M. Ruggeri, and T.S. Zimmerman. (1986) von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J. Biol. Chem. 261:381-385.
63) Blount, P., J.H. Elder, W.I. Lipkin, P.J. Southern, M.J. Buchmeier, and M.B.A. Oldstone. (1986) Dissecting the molecular anatomy of the nervous system: Analysis of RNA and protein expression in whole body sections of laboratory animals. Brain Research 382:257-265.
64) Elder, J.H., J.S. McGee, M. Munson, R. Houghten, J. Bittle, and C. Grant. (1987) Characterization of neutralizing epitopes on Feline Leukemia virus using monoclonal and anti-synthetic peptide antibodies. In: Vaccines 87. R. Chanock, F. Brown, R. Lerner, and H. Ginsberg (eds.). Cold Spring Harbor, NY, pp. 263-267.
65) Elder, J.H., J.S. McGee, M. Munson, R. Houghten, W. Kloetzer, J. Bittle, and C. Grant. (1987) Localization of neutralizing regions of the envelope gene of feline leukemia virus using anti-synthetic peptide antibodies. J. Virol. 61:8-15.
66) Nicolaisen-Strouss, K., H.P.M. Kumar, T. Fitting, C.K. Grant, andJ.H. Elder. (1987) Natural Feline Leukemia Virus Variant Escapes Neutralization by a Monoclonal Antibody Via an Amino Acid Change Outside the Antibody Binding Epitope. J. Virol. 61:3410-3415.
67) Herzog, N.K., B. Singh, J.H. Elder, I. Lipkin, R.J. Trauger, C.F. Millette, D.S. Goldman, H. Holfes, G.M. Cooper, and R.B. Arlinghaus. (1988) Identification of the protein product of the c-mos proto-oncogene in mouse testes. Oncogene 3:225-229.
68) Kumar, H.P.M, C.K. Grant, and J.H. Elder. (1989) Studies on the Development of a Synthetic Peptide Vaccine Against Feline Leukemia Virus. In: Synthetic Peptides: Approaches to Biological Problems. Alan R. Liss, Inc., NY, pp. 159-170.
69) Alexander, S. and J.H. Elder. (1989) Preparation and Properties of Endoglycosidases from Flavobacterium meningosepticum and their Application to Biological Problems. Methods in Enzymol. 179:505-518.
70) Talbott, R.L., E.E. Sparger, K.M. Lovelace, W.M. Fitch, P.A. Luciw, N.C. Pedersen, and J.H. Elder. (1989) Nucleotide sequence and genomic structure of feline immunodeficiency virus (FIV). Proc. Natl. Acad. Sci. USA. 86:5743-5747.
71) Pilet, C., F. Barre-Sinoussi, F. Quintin-Colonna, H.J. Boulouis, N.C. Pedersen, and J.H. Elder. (1989) Retroviroses Du Chat Et Retroviroses De L'Homme Elements de comparaison. Proc. French Natl. Acad. Med. 173:617-632.
72) Sparger, E.E., P.A. Luciw, J.H. Elder, J.K. Yamamoto, L.J. Lowenstine, and N.C. Pedersen. (1989) Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS 1:S43-9.
73) Trauger, R.J., R. Talbott, S.H. Wilson, R. Karpel and J.H. Elder. (1990) A single-stranded nucleic acid binding sequence common to the heterogeneous nuclear ribonucleoparticle protein A1 and murine recombinant virus GP70. J. Biol. Chem. 265:3674-3678.
74) Levy, L.S., P. Lobelle-Rich, J.H. Elder, S. Payne, and R.C. Montelaro. (1990) An unusual retroviruslike sequence identified in human DNA. J. Gen. Virol. 71:1613-1618.
75) Phillips, T., R. Talbott, C. Lamont, S. Muir, K. Lovelace and J.H. Elder. (1990) Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64:4605-4613.
76) Brown, W.C., L. Bissey, K.S. Logan, N.C. Pedersen, J.H. Elder, and E. W. Collisson. (1991) Feline immunodeficiency virus infects both CD4+ and CD8+ T Lymphocytes. J. Virol. 65:3359-3364.
77) Lamont, C., P. Culp, R.L. Talbott, T.R. Phillips, R.J. Trauger, W. Frankel, M.C. Wilson, J.C. Coffin and J.H. Elder. (1991) Characterization of endogenous and recombinant retroviral elements of a highly tumorigenic AKR cell line. J. Virol. 65:4619-4628.
78) Sparger, E.E., B.L. Shacklett, L. Renshaw-Gegg, P.A. Barry, N.C. Pedersen, J.H. Elder, and P.A. Luciw. (l992) Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187:165-177.
79) Hoover, E.A., N.A. Perigo, S.L. Quackenbush, C.K. Mathiason-DuBard, J.M. Overbaugh, W.S. Kloetzer, J.H. Elder, and J.I. Mullins. (l991) Protection against feline leukemia virus infection with an inactivated virus vaccine. J. Amer. Vet. Med. Assoc. 199:1392-1401.
80) Elder, J.H., D.L. Lerner, C.S. Hasselkus-Light, D.J. Fontenot, E. Hunter, P.A. Luciw, R.C. Montelaro, and T.R. Phillips. (l992) Distinct subsets of retroviruses encode deoxyuridine triphosphatase. J. Virol. 66:1791-1794.
81) Dandekar, S., A.M. Beebe, J. Barlough, T.R. Phillips, J. Elder, M. Torten,and N. Pedersen. (1992) Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J. Virol. 66:4040-4049.
82) Rideout, D., T. Calogeropoulou, K. Lovelace, C.D. Pauza, andJ.H. Elder. (1993) Derivatives of 4-Amino-3,6-disulfonatonaphthalimide inhibit retroviral reverse transcriptase and suppress feline immunodeficiency virus expression in cultured cells. J. Cell. Biochem. 51:446-457.
83) Fontenot, J.D., E.A. Hoover, J.H. Elder, and R.C. Montelaro. (1992) Evaluation of the diagnostic potential of the predicted immunodominant peptides of FIV and FeLV transmembrane proteins. J. Clin. Micro. 30:1885-1890.
84) Phillips, T.R., C. Lamont, D.A.M. Konings, B.L. Shacklett, P.A. Luciw, and J.H. Elder. (1992) Identification of the REV and REV responsive element of feline immunodeficiency virus. J. Virol. 66:5464-5471.
85) Elder, J.H., M. Schnölzer, C.S. Hasselkus-Light, M. Henson, D.L. Lerner, T.R. Phillips, P.C. Wagaman, and S.B.H. Kent. (1993) Identification of proteolytic processing sites within the gag and pol polyproteins of feline immunodeficiency virus.J. Virol. 67:1869-1876.
86) Elder, J.H. and T.R. Phillips, (1993) The genomic organization of FIV. In: Feline Immunology and Immunodeficiency. Willett, B. and Jarrett, O. (eds.). Oxford University Press, Oxford, United Kingdom, 14:220-242.
87) Wagaman, P.C., C.S. Hasselkus-Light, M. Henson, D.L. Lerner, T.R. Phillips, and J.H. Elder. (1993) Molecular cloning and characterizaton of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology 196:451-457.
88) Phillips, T.R., O. Prospero-Garcia, D.L. Puaoi, D.L. Lerner, H.S. Fox, R.A. Olmsted, F.E. Bloom, S.J. Henriksen, and J.H. Elder (1994) Neurological abnormalities associated with FIV infection. J. Gen. Virol. 75:979-987.
89) Elder, J.H. and T.R. Phillips. (1993) Molecular properties of feline immunodeficiency virus (FIV). Infectious Agents and Disease 2:361-374.
90) Thompson, F.J., J.H. Elder, and J.C. Neil. (1994) Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat. J. Gen. Virol. 75:545-554.
91) Elder, J.H. and T.R. Phillips. (1994) Feline immunodeficiency virus (FIV) as a model for development of molecular approaches to intervention strategies against lentivirus infections. Advances in Virus Research 45:225-247.
92) Prospero-Garcia, O., N. Herold, A. K. Waters, T. R. Phillips, J. H. Elder, and S. J. Henriksen. (1994) Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Research pp 254-258.
93) Prospero-Garcia, O., N. Herold, T. R. Phillips, J. H. Elder, F. E. Bloom and S. J. Henriksen. (1994) Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 91:12947-12951.
94) Sparger, E. E., A. M. Beebe, N. Dua, S. Himathongkam, J. H. Elder, M. Torten, and J. Higgins. (1994) Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology 205:546-553.
95) Henriksen, S.J., O. Prospero-Garcia, T.R. Phillips, H.S. Fox, F.E. Bloom, and J.H. Elder. (1995) FIV as a model for study of lentivirus infection of the CNS. In: Current Topic in Microbiology and Immunology: HIV and Dementia. Oldstone, M.B.A. and Vitkovic, L. (eds). Springer-Verlag, Berlin-Heidelberg-New York-Tokyo, pp 167-186.
96) Song, W., E. W. Collisson, J. Li, A. M. Wolf, J. H. Elder, C. K. Grant, and W. C. Brown. (1995) Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral. Virology 209:390-399.
97) Phillips, T. R., O.Prospero-Garcia, D.W. Wheeler, P.C.Wagaman, D. L. Lerner, H.S.Fox, L. R.Whalen, F. E.Bloom, J.H.Elder, and S. J. Henriksen. (1996) Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J. NeuroVirol. 2:388-396.
98) Lerner, D.L., P.C. Wagaman, T.R. Phillips, O. Prospero-Garcia, S.J. Henriksen, H.S. Fox, F.E. Bloom, and J.H. Elder. (1995) Increased mutation frequency of FIV lacking functional deoxyuridine triphosphatase, Proc. Natl. Acad. Sci. USA 92:7480-7484.
99) Slee, D. H., K. L. Laslo, J. H. Elder, and C.-H. Wong. (1995) Selectivity in the inhibition of HIV and FIV protease: exploiting new pyrrolidine-containing core structures for the development of structure and mechanism-based inhibitors, J. Amer. Chem. Soc. 117:11867-11878.
100) Schnölzer, M., H.-R. Rackwitz, A. Gustchina, A. Wlodawer, J. H. Elder, and S. B. H. Kent. (1995) Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis, Virology 224:268-275.
101) Li, J., W. C. Brown, W. Song, M. R. Carpino, A. M. Wolf., C. K. Grant, J. H. Elder, and E. W. Collisson. (1995) Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats, Virus Res. 38:93-109.
102) Waters, A. K., A. P. de Parseval, D. L. Lerner, J. C. Neil, F. J. Thompson, J. H. Elder. (1996) Influence of ORF2 on host cell tropism of feline immunodeficiency virus, Virology 215:10-16.
103) Prasad, G.S., E.A. Stura, D.E. McRee, G.S. Laco, C. Hasselkus-Light, J.H. Elder, and C.D. Stout. (1996) Crystal structure of dUTP pyrophosphatase from feline immunodeficiency virus, Protein Science 5:2429-2437.
104) von Schwedler, U., K. Townsend, S. Chada, D.J. Jolly, J. Elder, S.M. Chang, and W.T.L. Lee. (1996) Retroviral-mediated expression of FIV envelope.rev induces CD8+ CTL responses in mice, Intervirology 40:271-276.
105) Jacobsen, S., S.J. Henriksen, O. Prospero-Garcia, T.R. Phillips, J.H. Elder, F.E. Bloom, and H.S. Fox. (1997) Cortical neuronal cytoskeletal changes associated with FIV infection, J. NeuroVirol, 3:283-289.
106) Laco, G.S, M.C. Fitzgerald, G.M. Morris, A.J. Olson, S.B.H. Kent, andJ.H. Elder. (1997) Molecular analysis of the feline immunodeficiency virus protease; generation of a novel form of the protease by autoproteolysis and construction of cleavage resistant proteases, Journal of Virology 71:5505-5511.
107) de Parseval, A., D.L. Lerner, P. Borrow, B.J. Willett, and J.H. Elder. (1997) Blocking of FIV infection by a monoclonal antibody to CD9 is via inhibition of virus release, rather than interference with receptor binding, J. Virol., 71:5742-5749.
108) Laco, G.S., C. Schalk-Hihi, J. Lubkowski, G. Morris, A. Zdanov, A. Olson, J.H. Elder, A. Wlodawer, and A. Gustchina. (1997) Crystal structures of the inactive D30N mutant of FIV protease complexed with a substrate and an inhibitor, Biochemistry 36:10696-10708.
109) Fitzgerald, M.C., G.S. Laco, J.H. Elder, and S.B.H. Kent. (1997) A continuous flourometric assay for the FIV protease, Analytical Biochemistry, 254:226-230.
110) Lee, T., G.S. Laco, B.E. Torbett, H.S. Fox, D.L. Lerner, J.H. Elder, and C.-H. Wong. (1998) Analysis of the S3 and S3? subsite specificities of FIV protease; development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo, Proc. Natl. Acad. Sci., USA 95:939-944.
111)Elder, J.H., G.A. Dean, E.A. Hoover, J.A. Hoxie, M.H. Malim, J.C. Neil, T.W. North, M.B. Tompkins, W.A.F. Tompkins, N.C. Pedersen, and R.H. Miller. (1998) Lessons from the cat: Use of feline immunodeficiency virus (FIV) as a means to develop intervention strategies effective against human immunodeficiency virus type 1 (HIV). AIDS Res. in Human Retroviruses 14:797-801.
112) Groul, D.L., N. Yu, K.L. Parsons, J.N. Billaud, J.H. Elder, and T.R. Phillips. (1998) Neurotoxic effects of feline immunodeficiency virus, FIV-PPR, J. NeuroVirol., 4:415-425.
113) Lerner, D.L., C.K. Grant, A. de Parseval, and J.H. Elder. (1998) FIV infection of IL-2 dependent feline lymphocyte lines: host cell range distinctions and specific cytokine upregulation. Vet. Immunol. and Immunopath., 65:277-297.
114) Lee, T., V.-D. Le, Y.-C. Lin, A.L. Wong, J.H. Elder, and C.-H. Wong. (1998) Development of a new type of protease inhibitors with small P3 residue efficacious against FIV and HIV variants, J. Am. Chem. Soc., 121:1145-1155.
115) Johnston, J.C., M. Gasmi, J.-K. Yee, J.H. Elder, D.J.Jolly, and S.L. Sauter . (1998) Minimal requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors, J. Virol., 73:4991-5000.
116) Cao, W., M.D. Henry, P. Borrow , H. Yamada , J.H. Elder, E.V Ravkov, S.T. Nichol, R.W. Compans, K.P. Campbell, M.B. Oldstone. (1998) Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science., 282:2079-81.
117) Prospero-Garcia, O., S. Huitron-Resendiz, S.C. Casalman, M.Sanchez-Alavez, O. Diaz-Ruiz, L. Navarro, D.L. Lerner, T.R. Phillips, J.H. Elder, and S.J. Henriksen. (1999) Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats. Brain Research, 836:203-209.
118) de Parseval, A. andJ.H. Elder. (1999) Demonstration that orf2 encodes the feline immunodeficiency virus transactivation (Tat) protein and characterization of a unique gene product with partial Rev activity. J. Virol., 73:608-617.
119) Li, M., G.M. Morris, T. Lee, G.S. Laco, C.-H. Wong, A.J. Olson, J.H. Elder, A. Wlodawer, and A. Gustchina. (2000) Structural Studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease. Proteins 38: 29-40.
120) Dey, B., D.L. Lerner, P. Lusso, M.R. Boyd, J.H. Elder, and E.A. Berger. (2000) Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. J. Virol. 74:4562-4569.
121) Galicia, O., M. Sanchez-Alavez, O. Diaz-Ruiz, F. Sanchez Narvaez, J.H. Elder, L. Navarro, O. Prospero-Garcia. (2000) HIV-derived Protein gp120 Suppresses P3 Potential in Rats: Potential Implications in HIV-associated Dementia. Neuroreport 11:1351-1355.
122) Sanchez-Alavez, M., J. Criado, M. Gomez-Chavarin, A. Jimenez-Anguiano, L. Navarro, O. Diaz-Ruiz, O. Galicia, F. Sanchez Narvaez, E. Murillo-Rodriguez, S.J. Henriksen, J.H. Elder, O. Prospero-Garcia. (2000) HIV- and FIV-derivedgp120 Alter Spatial Memory, LTP, and Sleep in Rats. Neurobiol Dis 7:384-394.
123) Lerner, D.L. and J.H. Elder. (2000) Expanded host cell tropism and cytopathic properties of FIV-PPR subsequent to passage through interleukin-2 independent T cells. J. Virol., 74:1854-1863.
124) Chatterji, U., C.K. Grant and J.H. Elder. (2000) Feline immunodeficiency virus VIF localizes to the nucleus. J. Virol. 74:2533-2540.
125) Lin, Y.-C., Z. Beck, T. Lee, V.-D Le, G.M. Morris, A.J. Olson, C.-H. Wong, and J.H. Elder. (2000) Alteration of substrate and inhibitor specificity of FIV protease. J. Virol., 74:4710-4720.
126) Prasad, G.S., E.A. Stura, J.H. Elder, and C.D. Stout. (2000) Crystal structures of feline immunodeficiency virus dUTP pyrophosphatase and its nucleotide complexes in three crystal forms. Acta Cryst. D56:1100-1109.
127) Beck, Z., L. Hervio, P.E. Dawson, J.H. Elder, and E.L. Madison. (2000) Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development. Virology 274:391-401.
128) de Parseval, A and J.H. Elder. (2001) Binding of recombinant FIV surface gylcoprotein to feline cells: Role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75:4528-4539.
129) Mak, C.C., V-D Le, Y-C Lin, J.H. Elder, and C-H Wong. (2001) Design, Synthesis and Biological Evaluation of HIV/FIV Protease Inhibitors Incorporating a Conformationally Constrained Macrocycle with Small P3? Residue. Bioorganic and Medicinal Chemistry Letters, 11:2, 219-222.
130) Le, V-D, C.C. Mak, Y-C Lin, J.H. Elder and C-H Wong. (2001) Structure-Activity Studies of FIV and HIV Protease Inhibitors Containing Allophenylnorstatine. Bioorg Med Chem 9(5):1185-95.
131) Buehler, B, Y-C Lin, G. Morris, A.J. Olson, C-H Wong, D.D. Richman, J.H. Elder and B.E. Torbet. (2001) Viral Evolution in Response to the Broad-Based Retroviral Protease Inhibitor TL-3. J. Virol. 75:9502-9508.
132) Beck, Z.Q., Lin, Y-C and J.H. Elder. (2001) Molecular Basis for the Relative Substrates Specificity of HIV-1 and FIV Proteases. J. Virol.,75:9558-9469.
133) Diaz-Ruiz, Oscar, L. Navarro, M. Mendez-Diaz, O. Galicia, J.H. Elder, P. Sanna, R. Drucker-Colin, O. Prospero-Garcia. (2001) Inhibition of the ERK Pathway Prevents HIVgp120-Induced REM Sleep Increase. Brain Res 913(1):78-81.
134) Payne, S.L. and J.H. Elder. (2001) The Role of Retroviral dUTPases in Replication and Virulence. Current Protein and Peptide Science, 2:381-388.
135) Beck, Z.Q., G.M. Morris and J.H. Elder. (2002) Defining HIV-1 Protease Substrate Selectivity. Curr. Drug Targets: Infect. Disord. 2:37-50.
136) Chatterji, U., A. de Parseval, J.H. Elder. (2002) Feline Immunodeficiency Virus OrfA is Distinct from Other Lentivirus Transactivators. J. Virol. 76:9624-9634.
137) Hong, P.W-P., K.B. Flummerfelt, A. de Parseval, J.H. Elder, B. Lee. (2002) Human Immunodeficiency Virus Envelope (gp120) Binding to DC-SIGN and Primary Dendritic Cells is Carbohydrate Dependent but Does Not Involve 2G12 or Cyanovirin Binding Sites: Implications for Structural Analyses of gp120- DC-SIGN Binding. J. Virol., 76:12855-12865.
138) Brik, A., Y-C Lin, J.H. Elder and C-H Wong. (2002) A Quick Diversity-Oriented Amide-Forming Reaction to Optimize P-Subsite Residues of HIV Protease Inhibitors. Chemistry & Biology 9:891-896.
139) Mak, C.C., A. Brik, D.L. Lerner, J.H. Elder, G.M. Morris, A.J. Olson and C.H. Wong. (2003) Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases. Bioorg. Med. Chem.11:2025-2040.
140) Lin, Y-C, Z. Beck, G.M. Morris, A.J. Olson, and J.H. Elder . (2003) Structural Basis for Distinctions between Substrate and Inhibitor Specificities for FIV and HIV Proteases. J. Virol. 77:6589-6600.
141) Kutilek, V.D., D.A. Sheeter, J.H. Elder, and B.E. Torbett. (2003) Is Resistance Futile? Curr. Drug Targets: Infect. Disord. 3:295-308.
142) Huitron-Resendiz, S., S. de Rozieres, M. Sanchez-Alavez, B. Bühler, Y.-C. Lin, D.A. Lerner, N.W. Henriksen, M. Burudi, H.S. Fox, B.E. Torbett, S. Henriksen and J.H. Elder. (2004) Resolution and Prevention of FIV-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3. J. Virol. 78:4525-4532.
143) de Parseval, A., S.V. Su, J.H. Elder, and B. Lee. (2004) Specific Interaction of Feline Immunodeficiency Virus Surface Glycoprotein with Human DC-SIGN. J. Virol. 78:2597-2600.
144) Montes-Rodrigues, C.J., S. Alavez, S., J.H. Elder, R. Haro, J. Moran, O. Prospero-Garcia. (2004) Prolonged waking reduces human immunodeficiency virus glycoprotein 120- or tumor necrosis factor alpha-induced apoptosis in the cerebral cortex of rats. Neu Lt 360:133-136.
145) de Parseval, A., S. Ngo, P.Sun and J.H. Elder. (2004) Factors that Increase the Effective Concentration of CXCR4 Dictate Feline Immunodeficiency Virus Tropism and Kinetics of Replication. J. Virol. 78:9132-9143.
146) de Rozieres, S., C.K. Mathiason, M.R. Rolston, U. Chatterji, E.A. Hoover and J.H. Elder. (2004) Characterization of a Highly Pathogenic Molecular Clone of FIV-clade C. J. Virol. 78:8971-8982.
147) de Parseval, A., U. Chatterji, P. Sun and J.H. Elder. (2004) Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. PNAS. 101:13044-13049.
148) de Rozieres, S., C.H. Swan, D.A. Sheeter, K.J. Clingerman, Y.-C. Lin, S. Huitron-Resendiz, S. Henriksen, B.E. Torbett and J.H. Elder. (2004) Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor TL-3. Retrovirology 38:1-12.
149) de Parseval, A., U. Chatterji, G. Morris, P.Sun and J.H. Elder. (2005) Structural mapping of CD134 residues critical for interaction with FIV. Nat Struct Mol Biol. 12:60 ? 66.
150) Liang, F-S., A. Brik, Y-C. Lin, J.H. Elder and C-H. Wong. (2006) Epoxide Opening in the Water and Screening In Situ for Rapid Discovery Enzyme Inhibitors in Microtiter Plate.
Bioorganic & Medicinal Chemistry. 14(4):1058-62, PMID: 16275107.
151) Gonzalez-Lira, B., P.E. Rueda-Orozco, O. Galicia, C.J. Montes-Rodriguez, K. Guzman, M. Guevara-Martinez, J.H. Elder and O. Prospero. (2006) Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neuroscience Letters.394(2):136-9, PMID: 16269213.
152) Whiting, M., J. Muldoon, Y-C. Lin, S.M. Silverman, W. Lindstrom, A. Olson, H.C. Kolb,M.G. Finn, K.B. Sharpless, J.H Elder and V.V. Fokin. (2006) Inhibitors of HIV-1 Protease through In Situ Click Chemistry. Angew. Chem. Int. Ed. 44:1-5
153) Heaslet, H., V. Kutilek, G. Morris, Y.-C.Lin, J.H. Elder, B.E. Torbett, C.D. Stout. (2006) Structural Insights into the Mechanisms of Drug Resistance in HIV-1 Protease NL4-3.
Journal of Molecular Biology. 356(4):967-81.
154) de Parseval, A., C.K. Grant, J. Sastry, J.H. Elder. (2006) Sequential CD1334-CXCR4 Interactions in Feline Immunodeficiency Virus (FIV): Soluble CD134 Activates FIV Env
for CXCR-4 dependent Entry and Reveals a Cryptic Neutralization Epitope. Journal of Virology. 80(6):3088-91, PMCID: PMC1395450.
155) Binley J.M., S. Ngo-Abdalla, P. Moore, M. Bobardt, Chatterji, U., P. Gallay, D.R. Burton, I.A. Wilson, J.H. Elder, A. de Parseval. (2006) Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. Retrovirology. 3:39; correction (2007) 4:23, PMID: 16817962.
156) Lin, Y.C., A. Brik, A. de Parseval, K. Tam, B.E. Torbett, C.H. Wong, J.H. Elder. (2006) Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human
immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system. Journal of Virology. 80(16):7832-43, PMCID: PMC1563824.
157) Whiting, M., J.C. Tripp, Y.C. Lin, W. Lindstrom, A.J. Olson, J.H. Elder, K.B. Sharpless, V.V.Fokin. (2006) Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. J. Med. Chem. 49, 7697-7710.
158) Heaslet, H., Y.C. Lin, K. Tam, B.E. Torbett, J.H. Elder, C.D. Stout. (2007) Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3. Retrovirology 4:1, PMCID: PMC1781954.
159) Manuell, A.L., M.V. Beligni, J.H. Elder, D.T. Siefker, M. Tran, A. Weber, T.L. McDonald, S.P. Mayfield. (2007) Robust expression of a bioactive mammalian protein in
Chlamydomonas chloroplast. Plant Biotechnology Journal, 5.
160) Sundstrom M, Chatterji U, Schaffer L, de Rozières S, Elder JH. (2008) Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasomeubiquitination
proteins. Virology.20;371(2):394-404, PMID: 18289701.
161) Elder JH, Sundstrom M, de Rozieres S, de Parseval A, Grant CK, Lin YC. (2008) Molecular mechanisms of FIV infection. Vet Immunol Immunopathol. 2008 May 15;123(1-2):3-13 PMCID: PMC2409060.
162) de Rozières S, Thompson J, Sundstrom M, Gruber J, Stump DS, de Parseval AP, Vandewoude S, Elder JH. (2008) Replication Properties of Clade A/C Chimeric FIVs and Evaluation of Infection Kinetics in the Domestic Cat. J Virol. 82:7953-7963, PMID:
18550665.
163) Sundstrom M, White RL, de Parseval A, Sastry KJ, Morris G, Grant CK, Elder JH. (2008) Mapping of the CXCR4 Binding site within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein. J Virol. 2008 Jul 2, PMID: 18596086.
|
